首页> 外文期刊>Journal of drug targeting >Evaluation of multicomponent non-viral vectors for liver directed gene delivery.
【24h】

Evaluation of multicomponent non-viral vectors for liver directed gene delivery.

机译:肝脏指向基因递送的多组分非病毒载体的评价。

获取原文
获取原文并翻译 | 示例
           

摘要

Multicomponent, non-viral gene delivery vehicles are designed to have as a minimum, a DNA binding component, and a cell recognition component for specific delivery to target cells. The DNA binding component cannot only bind, but also protect DNA from serum degradation, and tends to condense DNA to sizes that can be taken up by receptor-mediated processes of target cells. Generally, cationic peptides, single chained, e.g. poly-L-lysine or branched polymers or synthetic peptides with DNA binding properties are used for DNA binding components. Ligands for binding to receptors on cell surfaces can be covalently linked to the DNA binding component. Multicomponent, non-viral vectors have been successfully used to deliver genes into cells in vitro and in vivo. Improvements have been made to the non-viral carriers resulting in increased solubility of DNA/carrier complexes and longer survival in serum. Improvements have also been made by incorporating fusogenic/lysosomolytic components that enable DNA/carrier complexes to escape intracellular degradation and enhance the levels and duration of expression of genes in vitro and in vivo.
机译:多组分,非病毒基因递送载体被设计为具有最小的DNA结合组分和用于特异性递送至靶细胞的细胞识别组分。 DNA结合组分不能只结合,但也可以保护DNA免受血清降解,并且趋于通过受体介导的靶细胞的受体介导的方法抑制DNA的尺寸。通常,阳离子肽,单链,例如,具有DNA结合性质的聚-L-赖氨酸或支链聚合物或合成肽用于DNA结合组分。用于与细胞表面上的受体结合的配体可以与DNA结合组分共价连接。多组分,非病毒载体已成功地用于在体外和体内将基因递送到细胞中。已经对非病毒载体进行了改进,导致DNA /载体络合物的溶解度增加,血清中的存活率较长。还通过掺入致沉菌/溶酶体分解组分来进行改进,使DNA /载体复合物能够逃避细胞内降解并增强体外和体内基因表达的水平和持续时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号